MarketsQuick read

Selmore Pharmaceuticals applies for PSX Main Board listing

Mettis Global • • 1 min read

Selmore Pharmaceuticals applies for PSX Main Board listing

Mettis Link News reported that Selmore Pharmaceuticals Limited has lodged an application to list its shares on the PSX Main Board. The company intends to sell 48,611,112 ordinary shares to the public, priced from a floor of Rs42 each.

Each share carries a Rs10 par value, and the sale will proceed through book building, which is the method specified for the offer. KTrade Securities Limited has been appointed as the lead manager for the issue.

Public comments on the draft prospectus were sought by the PSX, which placed the document on its website as required under Clause 3A(2) of the Public Offering Regulations, 2017. The details were also circulated to the market through a notice issued to the Exchange.

At a glance

  • Selmore Pharmaceuticals seeks a PSX Main Board listing through an IPO of 48,611,112 shares.
  • The floor price is Rs42 per share and each share has a par value of Rs10.
  • KTrade Securities Limited is lead manager, and the PSX has posted the draft prospectus for public comments.
Sectors:Pharmaceuticals

Originally reported by Mettis Global

This page is Investify's own summary. The full report, with all details and context, is on the publisher's site.

Read the full story

Want the full article here?

Log in to read the full article in the Investify reader, in English or Urdu.

Investify summarizes Pakistan Stock Exchange news in its own words and links each story to its original publisher. We always credit the source so you can read the full report and verify the details before making financial decisions.

Built for PSX investors

Business news.Every filing, summarised.

Top stories from Pakistan's business press and key findings from every PSX announcement.

Investify announcement summary with key findings from a PSX filing
Investify app home screen with Pakistan business news and PSX filings